|

Ligritinib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AB 801, AB-801, AB801, AXL Inhibitor AB801

Pipeline

Phase 1: 1

Top Sponsors

  • Jonsson Comprehensive Cancer Center1

Indications

  • Metastatic Cholangiocarcinoma1
  • Locally Advanced Cholangiocarcinoma1
  • Metastatic Pancreatic Adenocarcinoma1
  • Stage II Pancreatic Cancer AJCC v81
  • Locally Advanced Pancreatic Adenocarcinoma1

Los Angeles, California1 trial

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

UCLA / Jonsson Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.